Christopher R. Ireson

3.7k total citations · 2 hit papers
18 papers, 3.0k citations indexed

About

Christopher R. Ireson is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Christopher R. Ireson has authored 18 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Genetics and 4 papers in Oncology. Recurrent topics in Christopher R. Ireson's work include Estrogen and related hormone effects (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and Curcumin's Biomedical Applications (4 papers). Christopher R. Ireson is often cited by papers focused on Estrogen and related hormone effects (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and Curcumin's Biomedical Applications (4 papers). Christopher R. Ireson collaborates with scholars based in United Kingdom, Austria and Switzerland. Christopher R. Ireson's co-authors include Lloyd R. Kèlland, Andreas J. Gescher, William P. Steward, Donald J. L. Jones, Lawrence J. Marnett, Margaret M. Manson, Ricky A. Sharma, Munir Pirmohamed, Margaret L. Williams and Richard D. Verschoyle and has published in prestigious journals such as Blood, Gastroenterology and Cancer Research.

In The Last Decade

Christopher R. Ireson

18 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer.

2001 702 citations Ricky A. Sharma, Christopher R. Ireson et al. PubMed profile →
Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.

2001 506 citations Christopher R. Ireson, Donald J. L. Jones et al. PubMed profile →

Peers

Christopher R. Ireson

PHARM

ONCOL

PHYSI

Gaurisankar Sa India

Franck Morceau Luxembourg

Tanya Das India

Yuan‐Soon Ho Taiwan

David J. Boocock United Kingdom

Mysore S. Veena United States

A.R.M. Ruhul Amin United States

Tzong‐Der Way Taiwan

Thambi Dorai United States

Panayotis Pantazis United States

Gaurisankar Sa India

Christopher R. Ireson

2.3k ×1.4

1.3k ×0.9

309 ×0.8

PHARM

885 ×2.7

ONCOL

226 ×0.9

PHYSI

Citations per year, relative to Christopher R. Ireson Christopher R. Ireson (= 1×) peers Gaurisankar Sa

Countries citing papers authored by Christopher R. Ireson

Since Specialization

Citations

This map shows the geographic impact of Christopher R. Ireson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher R. Ireson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher R. Ireson more than expected).

Fields of papers citing papers by Christopher R. Ireson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher R. Ireson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher R. Ireson. The network helps show where Christopher R. Ireson may publish in the future.

Co-authorship network of co-authors of Christopher R. Ireson

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher R. Ireson. A scholar is included among the top collaborators of Christopher R. Ireson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher R. Ireson. Christopher R. Ireson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Raveendran, Sreejith, et al.. (2024). Combinatorial Therapy: Targeting CD133+ Glioma Stem-like Cells with a Polysaccharide–Prodrug Complex Functionalised Gold Nanocages. Biomedicines. 12(5). 934–934. 2 indexed citations

Ireson, Christopher R., Mohammad S. Alavijeh, Alan M. Palmer, Emily Fowler, & Hazel Jones. (2019). The role of mouse tumour models in the discovery and development of anticancer drugs. British Journal of Cancer. 121(2). 101–108. 138 indexed citations

Bernhart, Eva, Petra Heffeter, Andrea Wintersperger, et al.. (2014). Silencing of protein kinase D2 induces glioma cell senescence via p53-dependent and -independent pathways. Neuro-Oncology. 16(7). 933–945. 25 indexed citations

Bernhart, Eva, Andrea Wintersperger, Trevor DeVaney, et al.. (2013). Protein kinase D2 regulates migration and invasion of U87MG glioblastoma cells in vitro. Experimental Cell Research. 319(13). 2037–2048. 34 indexed citations

Ireson, Christopher R., Kuzhuvelil B. Harikumar, Amit Deorukhkar, et al.. (2010). 414 A Novel Small Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth Both In Vitro and In Vivo. Gastroenterology. 138(5). S–62. 4 indexed citations

Nahimana, Aimable, Antoine Attinger, Christopher R. Ireson, et al.. (2009). The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies. Blood. 113(14). 3276–3286. 150 indexed citations

Tozer, Gillian M., Simon Akerman, Neil A. Cross, et al.. (2008). Blood Vessel Maturation and Response to Vascular-Disrupting Therapy in Single Vascular Endothelial Growth Factor-A Isoform–Producing Tumors. Cancer Research. 68(7). 2301–2311. 83 indexed citations

Ireson, Christopher R., et al.. (2006). Cancer cell kill, in vivo biodistribution and antitumor properties of AS1411, a G-rich oligonucleotide aptamer. Cancer Research. 66. 1107–1108. 1 indexed citations

Ireson, Christopher R. & Lloyd R. Kèlland. (2006). Discovery and development of anticancer aptamers. Molecular Cancer Therapeutics. 5(12). 2957–2962. 386 indexed citations

10.

Newman, Simon P., Christopher R. Ireson, Helena J. Tutill, et al.. (2006). The Role of 17β-Hydroxysteroid Dehydrogenases in Modulating the Activity of 2-Methoxyestradiol in Breast Cancer Cells. Cancer Research. 66(1). 324–330. 53 indexed citations

11.

Ireson, Christopher R., Surinder K. Chander, A. Purohit, et al.. (2004). Pharmacokinetics of the nonsteroidal steroid sulphatase inhibitor 667 COUMATE and its sequestration into red blood cells in rats. British Journal of Cancer. 91(7). 1399–1404. 24 indexed citations

12.

Ireson, Christopher R., Surinder K. Chander, A. Purohit, et al.. (2004). Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents. British Journal of Cancer. 90(4). 932–937. 113 indexed citations

13.

Ireson, Christopher R., David C. Parish, Atul Purohit, et al.. (2003). Development of a sensitive high-performance liquid chromatography method for the detection of 667 COUMATE in vivo. The Journal of Steroid Biochemistry and Molecular Biology. 84(2-3). 337–342. 10 indexed citations

14.

Purohit, A., L. W. Lawrence Woo, Surinder K. Chander, et al.. (2003). Steroid sulphatase inhibitors for breast cancer therapy. The Journal of Steroid Biochemistry and Molecular Biology. 86(3-5). 423–432. 56 indexed citations

15.

Ireson, Christopher R., Donald J. L. Jones, Samantha Orr, et al.. (2002). Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine.. PubMed. 11(1). 105–11. 485 indexed citations

16.

Ireson, Christopher R., Donald J. L. Jones, Richard D. Verschoyle, et al.. (2001). Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.. PubMed. 61(3). 1058–64. 506 indexed citations breakdown →

17.

Sharma, Ricky A., Christopher R. Ireson, Margaret M. Manson, et al.. (2001). Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer.. PubMed. 7(7). 1894–900. 702 indexed citations breakdown →

18.

Sharma, Ricky A., Christopher R. Ireson, Richard D. Verschoyle, et al.. (2001). Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels.. PubMed. 7(5). 1452–8. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact